Jonathan Burkett

Chief Operations Officer / MedTech Strategy at TrackableMed
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Advertising Services
    • 1 - 100 Employee
    • Chief Operations Officer / MedTech Strategy
      • Sep 2021 - Present

      We help you avoid the frustration of lost advertising dollars by transforming your marketing into a scalable model that improves results for both patients and your company.Our clients have achieved outcomes such as:- Doubling the size of their practice in patient volume- Over $500,000/month in procedure reimbursement revenue for specialty practice- Expanding their business model to a national level- Average cost per appointment less than 2% of monthly advertising investment

    • Director of MedTech Market Strategy
      • Dec 2020 - Dec 2021

      TrackableMed, formerly known as Trackable Lead Generation, is a medical marketing agency and strategic partner for specialty practices, PPMs, and medical companies. With a service model rooted in behavioral science, our team has a proven track record for acquiring new patients, resulting in trackable growth for our clients.

    • Director of Accounts and Marketing
      • Jan 2016 - Dec 2020

    • Medical Device
    • 100 - 200 Employee
    • Titles held: US Marketing Manager, Key Accounts Manager & ENT Consultant
      • Aug 2008 - Dec 2015

      Ear, Nose, and Throat - From the early start-up phase with Acclarent, through several years after Johnson & Johnson's acquisition of Acclarent ($785M). Ear, Nose, and Throat - From the early start-up phase with Acclarent, through several years after Johnson & Johnson's acquisition of Acclarent ($785M).

    • United States
    • Medical Equipment Manufacturing
    • 700 & Above Employee
    • Titles held: District Sales Manager & Territory Manager
      • 2001 - Aug 2008

      Women's Health - From Novacept's early start-up phase through Cytyc's acquisition of Novacept ($325M), followed by Hologic's acquisition of Cytyc ($6.2B). Women's Health - From Novacept's early start-up phase through Cytyc's acquisition of Novacept ($325M), followed by Hologic's acquisition of Cytyc ($6.2B).

Education

  • Louisiana State University
    BFA, Fine Arts and Graphic Design

Community

You need to have a working account to view this content. Click here to join now